Nongynecologic cytology practice guideline

Acta Cytologica

Volumn 48, Issue 4, 2004, Pages 521-546

  Cortese, Cherise ^a   DeMay, Richard M ^a   McGahey Frain, Barbara ^a   Grossl, Norman ^a   Moriarty, Ann T ^a   Prey, Marianne U ^a   Sharamitaro, Norma ^a   Van Duzer, Shirley ^a  

^a NONE

Author keywords

Clinical laboratory techniques; Nongynecologic cytology; Practice guideline

Indexed keywords

CYTOLOGY; CYTOPATHOLOGY; FINANCIAL MANAGEMENT; HUMAN; INFORMATION PROCESSING; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TISSUE PREPARATION;

EID: 3242691554     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326414     Document Type: Review

References (167)

1. Institute of Medicine, Committee on Clinical Practice Guideline: Guideline for Clinical Practice: From Development to Use. Edited by MJ Field, KN Lohr. Washington, DC, National Academy Press, 1992, p 8
2. Institute of Medicine: Clinical Practice Guideline: Directions for a New Program. Edited by MJ Field, KN Lohr. Washington, DC, National Academy Press, 1990, p 39
3. American Medical Association: Directory of Clinical Practice Guideline: Titles, Sources, and Updates. Chicago, AMA, 1997
4. Department of Health and Human Services, Health Care Financing Administration, Public Health Service, 42 CFR 405 et seq, 57 FR 7002-7186, February 28, 1992 [revising regulations applicable to laboratories and implementing provisions of the Clinical Laboratory Improvement Amendments of 1988, P.L. 100-578]
5. College of American Pathologists: Commission on Laboratory Accreditation (www.cap.org)
6. College of American Pathologists: Commission on Laboratory Accreditation Inspection Checklist. Northfield, Illinois, CAP, 2002
7. Naylor B: Pleural, peritoneal, and pericardial fluids. In Comprehensive Cytopathology. Edited by M Bibbo. Philadelphia, WB Saunders Co, 1997, pp 541-614
8. National Committee for Clinical Laboratory Standards: Nongynecologic Cytologic Specimens: Collection and Cytopreparatory Techniques: Approved Guideline. Wayne, Pennsylvania, NCCLS, 1999
9. Occupational Safety and Health Administration: Bloodborne Pathogens. Standard 1910.1030. Washington, DC, OSHA, 2001
10. Venrick MG, Sidawy MK: Cytologic evaluation of serous effusions: Processing techniques and optimal number of smears for routine preparation. Am J Clin Pathol 1993;99: 182-186
11. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1242(a)
12. Keebler CM: Cytopreparatory techniques. In Comprehensive Cytopathology. Philadelphia, WB Saunders, 1991, pp 881-906
13. Somrak TM, Sorensen K, Abdul-Karim F: Pap Smear: Collection, Handling and Quality Assurance. Chicago, ASCP Press, 1990
14. DeMay RM: The Art and Science of Cytopathology. Chicago, ASCP Press, 1996
15. Yang GC, Alvarez II: Ultrafast Papanicolaou stain: An alternative preparation for fine needle aspiration cytology. Acta Cytol 1995;39:55-60
16. Yang GC: Ultrafast Papanicolaou stain is not limited to rapid assessment: Application to permanent fine-needle aspiration smears. Diagn Cytopathol 1995;13:160-162
17. National Committee for Clinical Laboratory Standards: Fine Needle Aspiration Biopsy (FNAB) Techniques: Approved Guideline. Second edition. Wayne, Pennsylvania, NCCLS, 2002
18. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80
19. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1241(c)(1)
20. National Committee for Clinical Laboratory Standards: Procedures for the Handling and Transport of Diagnostic Specimens and Etiologic Agents. Third edition. Approved Standard (1994). Wayne, Pennsylvania, NCCLS, 1994
21. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1241(a)
22. Triol JH (editor): ASCT Cytopathology Quality Assurance Guide. First and second volumes. Raleigh, North Carolina, American Society for Cytotechnology, 1992
23. Bales CE, Durfee GR: Cytologic techniques. In Diagnostic Cytology and its Histologic Basis. Fourth edition. Edited by LG Koss. Philadelphia, JB Lippincott, 1992, pp 1452-1514
24. Boon ME: Routine cytologic staining procedures. In Compendium on Diagnostic Cytology. Edited by GL Wied, CM Keebler, LG Koss, JW Reagan. Chicago, Tutorials of Cytology, 1992, pp 579-584
25. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1232
26. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1241(b)
27. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1283(a)
28. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1251(b)(1)
29. Papanicolaou Society of Cytopathology Task Force on Standards of Practice: Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting. Diagn Cytopathol 1997;17:239-247
30. ThinPrep® 2000 System Operator's Manual. Boxborough, Massachusetts, Cytyc Corporation, 1995
31. PrepStain™ System Operator's Manual. Burlington, North Carolina, TriPath Imaging™
32. Diaz-Rosario LA, Kabawat SE: Cellblock preparation by inverted filter sedimentation is useful in the differential diagnosis of AGUS in ThinPrep specimens. Cancer Cytopathol 2000;90:265-272
33. Richard K, Dziura B, Hornish A: Cell block preparation as a diagnostic technique complementary to fluid-based monolayer cervicovaginal specimens. Acta Cytol 1999;43:69-73
34. Rowe LR, Marshall CJ, Bentz JS: Cell block preparation as an adjunctive diagnostic technique in ThinPrep monolayer preparations: A case report. Diagn Cytopathol 2001;24:142-144
35. Yeoh GP, Chan KW: Cell block preparation on residual ThinPrep sample. Diagn Cytopathol 1999;21:427-431
36. Homquist MD, Keebler CM: Cytopreparatory techniques. In The Manual of Cytotechnology. Seventh edition. Edited by CM Keebler, TM Somrak. Chicago, ASCP Press, 1993, pp 414-417
37. National Committee for Clinical Laboratory Standards: Papanicolaou Technique: Approved Guideline. Villanova, Pennsylvania, NCCLS, 1994
38. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1251(b)(4)
39. Morris MW, Davey FR: Basic examination of blood. In Clinical Diagnosis and Management by Laboratory Methods. Twentieth edition. Edited by JB Henry. Philadelphia, WB Saunders, 2000
40. Whatman: (www.whatman.com)
41. Gill GW: A cross-contamination control and stain storage system. Cytotechnol Bull 1975;12:12-13
42. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(b)(2)(3)
43. Occupational Safety and Health Administration: Occupational Exposures to Chemicals in Laboratories. Federal Register Final Rules, title 29.1910.1450, 1990
44. American Society Testing and Materials, 100 Barr Harbor Drive, West Conshohocken, Pennsylvania (http://www.astm.org)
45. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1100(a)(b)(d)
46. Carriere C: The cytotechnologist and the workplace. In The Manual of Cytotechnology. Seventh edition. Edited by CM Keebler, TM Somrak. Chicago, ASCP Press, 1993, pp 351-355
47. Patten FW: Organization of the Laboratory. In Compendium on Diagnostic Cytology. Sixth edition. Edited by GL Wied, CM Keebler, LG Koss, JW Reagan. Chicago, Tutorials of Cytology, 1990, pp 589-593
48. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(e)(3)
49. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 1992;57:493.1449
50. Cervical cytology practice guidelines: American Society of Cytopathology. Acta Cytol 2001;45:201-226
51. Occupational Safety and Health Administration: Occupational exposure to blood borne pathogens. Federal Register, Final Rules, title 29. 1991;56(235), amended 1996;60 (30)
52. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(d)
53. Cervical Cytology Practice Guidelines: American Society of Cytopathology. Acta Cytol 2001;45:201-226
54. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(d)(2)(iii)
55. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1291(c)
56. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1291(f)
57. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1283(a)(3)
58. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1291(g)
59. DeMay RM: The Art and Science of Cytopathology. Second volume. Chicago, ASCP Press, 1996
60. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1291(i)(1)(2)(3)
61. National Committee for Clinical Laboratory Standards: A Quality System Model for Respiratory Services: Proposed Guideline. Wayne, Pennsylvania, NCCLS, 2000
62. Quality Improvement Manual in Anatomic Pathology. Chicago, College of American Pathologists, 1993
63. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274
64. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1255
65. Zarbo RJ: Monitoring anatomic pathology practice through quality assurance measures. Clin Lab Med 1999;19:713-742
66. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 1992;57:493.1449, 1483
67. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(d)(2)(iv)
68. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(d)(1)
69. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(e)(5)
70. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(e)(3)
71. Nagy GK: False negative rate: A misnomer, misunderstood and misused. Acta Cytol 1997;41:778-780
72. Krieger PA, Naryshkin S: Random rescreening of cytologic smears: A practical and effective component of quality assurance programs in both large and small cytology laboratories. Acta Cytol 1994;38:291-298
73. Krieger PA, Cohen T, Naryshkin S: A practical guide to Papanicolaou smear rescreens. Cancer Cytopathol 1998;84: 130-137
74. Rickert RR: Quality assurance in anatomic pathology. Clin Lab Med 1986;6:697-706
75. Centers for Disease Control and Prevention: HIPAA privacy rule and public health. MMWR Morbid Mortal Wkly Rep 2003;52:1-12
76. Buffone GJ, Moreau D, Beck JR: Workflow computing: Improving management and efficiency of pathology diagnostic services, Am J Clin Pathol 1996;105:S17-S24
77. Clinical Laboratory Improvement Amendments of 1988: Final Rule, Federal Register 2003;68:493.1274(f)
78. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1291(a)
79. Aller R: The laboratory information system a medical device: Inspection and accreditation issues. Clin Lab Management Rev 1992;6:58-64
80. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1253
81. Kini SR: Color Atlas of Differential Diagnosis in Exfoliative and Aspiration Cytology. Philadelphia, Williams & Wilkins, 1999
82. Frisman D: ImmunoQuery Web site (www.ipox.org)
83. Dabbs DJ: Diagnostic Immunochemistry. Philadelphia, Churchill Livingstone, 2002
84. Bibbo M (editor): Comprehensive Cytopathology. Second edition. Philadelphia, WB Saunders, 1997, pp 965-983
85. O'Leary TJ: Advanced Diagnostic Methods in Pathology. Philadelphia, WB Saunders, 2003
86. Waters JJ, Barlow AL, Gould CP: Demystified...FISH. Mol Pathol 1998;51:62-70
87. Bergeron C, Ferenzcy A: In situ hybridization. In Comprehensive Cytopathology. Edited by M Bibbo. Philadelphia, WB Saunders, 1995, pp 1053-1060
88. DeMay RM: The Art and Science of Cytopathology. Chicago, ASCP Press, pp 86-87
89. Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR: Fluorescence in situ hybridization (FISH): A user's guide to optimal preparation of cytologic specimens. Diagn Cytopathol 1995;13:486-492
90. Wolman SR, Sanford JS, Flom K, Feiner H, Abati A, Bedrossian C: Genetic probes in cytology: Principles and applications. Diagn Cytopathol 1995;13:429-435
91. Dabbs DJ: Diagnostic Immunohistochemistry. Edinburgh, Churchill Livingstone, 2002, pp 17-20
92. Ross JS: Ancillary Techniques in Diagnostic Cytopathology: Uses and Limitations. United States and Canadian Academy of Pathology, 2001, pp 1-65
93. Appendix C: Survey Procedures and Interpretive Guideline for Laboratories and Laboratory Services. Washington, DC, Department of Health and Human Services, Health Care Financing Administration, 1993, pp 1-296
94. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1105(a)(7)
95. Clinical Laboratory Improvement Amendments of 1988: Final Rule. Federal Register 2003;68:493.1274(f)
96. National Committee for Clinical Laboratory Standards: Basic Cost Accounting for Clinical Services: Approved Guidelines. Wayne, Pennsylvania, NCCLS, 1998
97. Coiles R: Market outlook: Seven strategies for tomorrow's clinical laboratories. Health Trends 2001;13:9-12
98. Auxter S: The rebirth of America's clinical laboratory industry? Clin Lab News January 2001
99. Paxton A: Bean counting basics for laboratories. CAP Today 2001;15:22
100. Template topics: Calculating costs. Clin Leadership Managem Rev March/April 2001, pp 124-127
101. A systematic approach to direct cost analysis: The experience of one lab with labor and supply cost allocations. Clin Leadership Managem Rev
102. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36
103. US Environmental Protection Agency: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorder in Children. Washington, DC, EPA, 1990
104. US Environmental Protection Agency: Environmental Tobacco Smoke: A Guide to Workplace Policies. Washington, DC, EPA, 1990
105. Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest (suppl 1) 2003;123:21S-49S
106. Brownson RC, Figgs LW, Caisley LE: Epidemiology of environmental tobacco smoke exposure. Oncogene 2002; 21:7341-7348
107. Centers for Disease Control and Prevention, Office of Smoking and Health: Health Benefits of Smoking Cessation: A Report of the Surgeon General. Washington DC, US Government Printing Office, 1990
108. Auerbach O, Garfinkel L: The changing pattern of lung carcinoma. Cancer 1991;68:1973-1977
109. Chyou P-H, Nomura AMY, Stemmermann GN: A prospective study of the attributable risk of cancer due to cigarette smoking. Am J Public Health 1992;82:37-40
110. Greenberg SD, Fraire AE, Kinner BM, Johnson EH: Tumor cell type versus staging in the prognosis of carcinoma of the lung. Pathol Annul 1987;22:387-405
111. Jett JR, Cortese DA, Fontana RS: Lung cancer: Current concepts and prospects. CA Cancer J Clin 1983;33:74-86
112. Morton WE, Treyve EL: Histologic differences in occupational risks of lung cancer incidence. Am J Indust Med 1982;3:441-457
113. Fielding JE: Smoking: Health effects and control. N Engl J Med 1985;313:491-561
114. Garfinkel L, Silverberg E: Lung cancer and smoking trends in the United States over the past 25 years. CA Cancer J Clin 1991;41:137-145
115. Hammond EC: Smoking in Relation to the Death Rates of One Million Men and Women. NCI Monogr 1966;19:127-204
116. Linnoila I: Pathology of non-small cell lung cancer: New diagnostic approaches. Hematol Oncol Clin North Am 1990;4:1027-1051
117. Carney DN: Biology of small-cell lung cancer. Lancet 1992;339:843-846
118. Whitesell PL, Drage CW: Occupational lung cancer. Mayo Clin Proc 1993;68:183-188
119. Fontham ETH: Protective dietary factors and lung cancer. Int J Epidemiol (suppl 1) 1990;19:S32-S42
120. Pershagen G, Akerblom G, Axelson O, Clavensjo B, Damber L, Desai G, Enflo A, Lagarde F, Mellander H, Svartengren M, Swedjemark GA: Residential radon exposure and lung cancer in Sweden. N Engl J Med 1994;330: 159-164
121. Samet JM: Indoor radon and lung cancer: Estimating the risks. N Engl J Med 1992;156:25-29
122. Amos CI, Caporaso NE, Weston A: Host factors in lung cancer: A review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev 1992;1:505-513
123. Ives JC, Buffler PA, Greenberg SD: Environmental associations and histopathologic patterns of carcinoma of the lung: The challenge and dilemma in epidemiologic studies. Am Rev Respir Dis 1983;128:195-209
124. Law MR: Genetic predisposition to lung cancer. Br J Cancer 1990;61:195-206
125. Saccomanno G, Huth GC, Auerbach O, Kuschner M: Relationship of radioactive radon daughters and cigarette smoking in the genesis of lung cancer in uranium miners. Cancer 1988;62:1402-1408
126. Berry G, Newhouse ML, Turok M: Combined effect of asbestos exposure and smoking on mortality from lung cancer in factory workers. Lancet 1972;2:476-479
127. Churg A: Asbestos, asbestosis, and lung cancer. Mod Pathol 1993;6:509-511
128. Hammond E, Selikoff IJ, Seidman H: Asbestos exposure, cigarette smoking, and death rates. Ann N Y Acad Sci 1979; 330:473-490
129. Selikoff IJ, Hammond EC, Churg J: Asbestos exposure, smoking, and neoplasia. JAMA 1968;204:104-112
130. Skillrud DM, Offord KP, Miller RD: Higher risk of lung cancer in chronic obstructive pulmonary disease: A prospective, matched, controlled study. Ann Intern Med 1986;105: 503-507
131. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496-499
132. Yousem SA, Ohori NP, Sonmez-Alpan E: Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992;69:693-697
133. Cho JY, Kim JH, Lee YH, Chung KY, Kim SK, Gong SJ, You NC, Chung HC, Roh JK, Kim BS: Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer 1997;79:462-467
134. Gazdar A: The molecular and cellular basis of human lung cancer. Anticancer Res 1994;13:261-267
135. Salgia R, Skarin AT: Molecular abnormalities in lung cancer. J Clin Oncol 1998;16:1207-1217
136. Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC: Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316
137. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr: Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89: 1580-1586
138. Gazdar AF, Minna JD: Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 1997;89:1563-1565
139. Petty TL: The early identification of lung cancer by sputum cytology. Cancer (suppl) 2000;89:2461-2464
140. American Cancer Society: Guidelines for the Cancer-Related Checkup: An Update. Atlanta, American Cancer Society, 1993
141. American Academy of Family Physicians: Age Charts for Periodic Health Examination. Kansas City, Missouri, AAFP, 1994
142. American College of Radiology: ACR Standard for Adult Chest Radiography. Second edition. Reston, Virginia, ACR, 1993
143. Screening for adult respiratory disease: Official American Thoracic Society statement. Am Rev Resp Dis 1983;128: 768-774
144. Eddy DM: Common Screening Tests. Philadelphia, American College of Physicians, 1991, pp 312-325
145. Canadian Task Force on the Periodic Health Examination: Canadian Guide to Clinical Preventive Health Care. Ottawa, Canada Communication Group, 1994, pp 780-787
146. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, Sidransky D: Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;91:332-339
147. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP: Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 1999;354:99-105
148. DeMay RM: Respiratory cytology. The Art and Science of Cytopathology. Chicago, ASCP Press, 1996
149. Papanicolaou GN: Atlas of Exfoliative Cytology. Cambridge, Massachusetts, Harvard University Press, 1954
150. Johnston WW, Bossen EH: Ten years of respiratory cytopathology at Duke University Medical Center: I. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol 1981;25:103-107
151. Popov TA, Pizzichini MM, Pizzichini E, Kolendowicz R, Punthakee Z, Dolovich J, Hargreave FE: Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J 1995;8:559-565
152. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters SP, Sorkness C, Szefler SJ; NHLBI Asthma Clinical Research Network: Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001;163:1470-1475
153. Fireman E: Induced sputum: Opening a new window to the lung. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:263-271
154. Leigh TR, Parsons P, Hume C, Husain OA, Gazzard B, Collins JV: Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet 1989;2:205-206
155. Jay SJ, Wehr K, Nicholson DP, Smith AL: Diagnostic sensitivity and specificity of pulmonary cytology: Comparison of techniques used in conjunction with flexible fiberoptic bronchoscopy. Acta Cytol 1980;24:304-312
156. Bender BL, Cherock M, Sotos SN: Effective use of bronchoscopy and sputa in the diagnosis of lung cancer. Diagn Cytopathol 1985;1:183-187
157. Tang CS, Tang CM, Lau YY, Kung IT: Sensitivity of sputum cytology after homogenization with dithiothreitol in lung cancer detection: Two years of experience. Acta Cytol 1995; 39:1137-1140
158. Tang CS, Tang CM, Kung IT: Dithiothreitol homogenization of prefixed sputum for lung cancer detection. Diagn Cytopathol 1994;10:76-81
159. Tang CS, Kung IT: Homogenization of sputum with dithiothreitol for early diagnosis of pulmonary malignancies. Acta Cytol 1993;37:689-693
160. Tockman MS, Qiao Y, Li L, Zhao GZ, Sharma R, Cavenaugh LL, Erozan YS: Safe separation of sputum cells from mucoid glycoprotein. Acta Cytol 1995;39:1128-1136
161. Lindner J, Rennard S: Bronchoalveolar Lavage. Chicago, ASCP Press, 1988
162. Abati A, Landucci D, Danner RL, Solomon D: Diagnosis of microvascular metastases by cytologic evaluation of pulmonary artery catheter-derived blood specimens. Hum Pathol 1994;25:257-262
163. Masson RG, Krikorian J, Lukl P, Evans GL, McGrath J: Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med 1989;321:71-76
164. Kobzik L: The Lung. In Robbins Pathologic Basis of Disease. Sixth edition. Edited by RS Cotran, V Kumar, T Collins. Philadelphia, WB Saunders, 1999, pp 697-755
165. DeMay RM: Fluids. The Art and Science of Cytopathology. Chicago, ASCP Press, 1996
166. Saccomanno G, Saunders RP, Ellis H, Archer VE, Wood BG, Beckler PA: Concentration of carcinoma or atypical cells in sputum. Acta Cytol 1963;7:305-310
167. O'Leary TJ: Advanced Diagnostic Methods in Pathology. Philadelphia, WB Saunders, 2003